“Artificial pancreas” receives FDA approval.

The Wall Street Journal (9/27, Tadena, Subscription Publication, 5.91M) reported the Food and Drug Administration approved Medtronic Inc.’s insulin delivery pump, the MiniMed 530G “artificial pancreas.” The device is approved for use in people over 16 years of age with diabetes.

        Bloomberg News (9/27, Cortez, 1.91M) noted the device’s “approval came about six months earlier than investors expected.” According to Bloomberg News, “the next generation device will be designed to anticipate blood sugar levels and administer insulin accordingly to keep patients in an ideal range with little patient involvement.”

        Also reporting on the story are Reuters (9/27, Dey), the Minneapolis-St. Paul (MN) Business Journal (9/30, Grayson, Subscription Publication, 13K) “TechFlash” blog, the Minneapolis Star Tribune (9/28, Moore, 1.14M), theLos Angeles Business Journal (9/27, 98K), and Medscape (9/30, Tucker, 164K).